miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA.

Source:http://linkedlifedata.com/resource/pubmed/id/19098714

Download in:

View as

General Info

PMID
19098714